Hologic, Inc. (NASDAQ:HOLX) Receives Health Canada Authorization to Market SculpSure® Laser

1109

Hologic, Inc. (NASDAQ:HOLX) has announced that it has been issued with a medical device license by Health Canada that will allow the company to market SculpSure, Cynosure’s advanced non-invasive body contouring product. SculpSure is used in the treatment of inner, outer and back thighs as well as submental area.

As opposed to other technologies, SculpSure uses laser to increase the temperature of fats in the body so as to disrupt and destroy fats cells that are beneath the skin. The whole process is aimed at helping the patient attain a slimmer and natural-looking appearance. The body then gets rid of the fat cells naturally.

It is important to note that SculpSure laser body treatments are mainly recommended for patients that have a body mass index that is 30 or below. SculpSure laser submental treatments are very effective on patient that have body mass index of up to 43. This is a big advantage over its main competitor cryolipolysis, which has been approved for treatment of patients that have a body mass index of 30 in the submental area.

In a statement, Hologic President in charge of the Cynosure division Kevin Thornal said that the license is a clear indication of the company’s commitment to research as well as working hard to meet the needs of millions of patients. He added that being the leading company in medical aesthetics, they are always working hard to secure new indications which offer exceptional efficacy.

The authorization will be for outer, inner and back thighs and will not need any update to devices purchased previously. However, the submental treatment will need qualified practitioners to do an upgrade of their SculpSure device and but a much simple laser attachment with the allowance for the applicator to fit smoothly onto the area being treated. The sales team will start distribution immediately to interested practitioners.

Cynosure is one of the leaders in the development and manufacturing of several medical aesthetics systems and technologies. The company boasts of an extensive portfolio of over 20 products in major categories including skin revitalization, body contouring, women’s health and hair removal.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.